LAG3 and ovarian cancer: LSECtin binds to LAG-3 to inhibit the secretion of IFN-γ by effector T cells in melanoma, thereby inhibiting the antitumour immune response.41 Blocking LAG-3 leads to increased accumulation and effector function of CD8+ T cells in ovarian cancer.42,43